Appendix 3H - Notification of cessation of securities Announcement Summary Entity name ACTINOGEN MEDICAL LIMITED Announcement Type New announcement Date of this announcement Thursday November 12, 2026 Details of +securities that have ceased Number of ASX +security +securities that The +securities...
Notification of cessation of securities - ACW
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Actinogen Medical Limited has filed a notification regarding the cessation of certain securities. Following this cessation, the total number of quoted equity securities will be updated accordingly.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Actinogen Medical Limited on 6ix
Earlier from Actinogen Medical
- Update - Notification of buy-back - ACW
- Response to ASX Price Query
- Letter to Shareholders, Notice of AGM & Proxy Form
- Actinogen receives $10.8m R&D tax incentive rebate from ATO
- ACW pivotal Alzheimers trial database lock - results mid-Nov
Later from Actinogen Medical
- Trading Halt
- Request for Trading Halt
- Suspension from Quotation
- ACW XanaMIA Alzheimers trial results
- Reinstatement to Quotation
Follow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical